Skip to main content
. 2022 Jul 29;16:2385–2390. doi: 10.2147/OPTH.S368214

Table 3.

Overall Rates of Adverse Events After Switch from 0.01% to 0.03% Bimatoprost

Total Population n=143
Total patients with any adverse events, n (%) 42 (29)
 Hyperemia 23 (16)
 Ocular surface disease 13 (9)
 Eyelid erythema 5 (3)
 Pigmentary cells 4 (3)
 Eye pruritus 4 (3)
 Cystoid macular edema 2 (1)
 Other 4 (3)